0 followers
TenSixteen Bio is the first company to leverage somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics to treat age-related diseases.
Industries
Headquarters
Stage
Employees
Links
4 members
0 members
1 members
Bio-Rad Laboratories
11 followers
BioMarin Pharmaceutical
21 followers
Adaptive Biotechnologies
Agilent Technologies
60 followers
Regeneron
77 followers
Discover companies